Sat, Sep 20, 2014, 12:02 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

thirdmeinvestor 26 posts  |  Last Activity: Aug 4, 2014 9:29 PM Member since: Feb 25, 2004
  • Reply to

    A post from facebook:

    by gladpick Jun 6, 2014 11:24 AM
    thirdmeinvestor thirdmeinvestor Jun 23, 2014 10:12 PM Flag

    The same person (most likely) posted the following blog on May 30 two weeks after the one you posted appeared. In both blogs she wrote without using punctuation marks.

    [[ Judy Law My daughter took part in this study in england it was double blinded for 6 months but now she is taking the active drug [there has to be a "period" here (my comment)] when she started in september she just managed to get on the trial with a lung function of 40% [another period is missing here] to cut a long story short we dont know any results from the trial but we do from the clinic visits weight is up to 56kg sats stable at 96_98 and her lung function at last visit was a whooping 59 % x x ]]

    It is possible this person manufactured this story to encourage other CF persons, but it is likely that she has a valid story to tell because the blogs appeared in QUEST for KALYDECO.

  • Reply to

    809 combo and responders

    by verityvoila Jun 23, 2014 6:50 AM
    thirdmeinvestor thirdmeinvestor Jun 23, 2014 3:00 PM Flag

    Verity, my response to your post does not show here.

  • Reply to

    809 combo and responders

    by verityvoila Jun 23, 2014 6:50 AM
    thirdmeinvestor thirdmeinvestor Jun 23, 2014 2:58 PM Flag

    Verity, I like the results from JP Morgan models, which give:

    FEV-1 improvement

  • Reply to

    A post from facebook:

    by gladpick Jun 6, 2014 11:24 AM
    thirdmeinvestor thirdmeinvestor Jun 23, 2014 1:29 PM Flag

    Don't get confused about individual's data with group averages. In the 661 Ph 2 trial, one 508 patient who is receiving a placebo had an increase of 26% for FEV1. Does it mean that the patient is faking! All are 508 homozygous patients, but the dispersion is huge.

  • Reply to

    A post from facebook:

    by gladpick Jun 6, 2014 11:24 AM
    thirdmeinvestor thirdmeinvestor Jun 23, 2014 12:00 PM Flag

    Getrich, the story quoted by Gladpick from Facebook sounds so real and internally consistent that it is very unlikely a fabrication. The daughter started the trial in September last year and finished the trial in March, then put on the extension study.

  • Reply to

    what is needed for approval?

    by verityvoila Jun 20, 2014 12:11 PM
    thirdmeinvestor thirdmeinvestor Jun 22, 2014 8:33 PM Flag

    The rollover study is also supposed to be a double-blinded trial, but some participants are finding out good enhancement for FEV1 and weight gains. Getrich, do you have anecdotal stories to tell?

VRTX
103.75+6.40(+6.57%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.